Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, pha... by Blonde, Lawrence, MD, Jendle, Johan, MD, Gross, Jorge, Prof, Woo, Vincent, MD, Jiang, Honghua, PhD, Fahrbach, Jessie L, MD, Milicevic, Zvonko, Dr

Get full text

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial by Bailey, Clifford J, Prof, Gross, Jorge L, Prof, Pieters, Anne, MS, Bastien, Arnaud, MD, List, James F, MD

Get full text

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial by Cuzick, Jack, Prof, Sestak, Ivana, PhD, Forbes, John F, Prof, Dowsett, Mitch, Prof, Knox, Jill, MSc, Cawthorn, Simon, MD, Saunders, Christobel, Prof, Roche, Nicola, MD, Mansel, Robert E, Prof, von Minckwitz, Gunter, MD, Bonanni, Bernardo, MD, Palva, Tiina, MD, Howell, Anthony, Prof

Get full text

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial by le Roux, Carel W, Prof, Astrup, Arne, Prof, Fujioka, Ken, MD, Greenway, Frank, Prof, Lau, David C W, Prof, Van Gaal, Luc, Prof, Ortiz, Rafael Violante, MD, Wilding, John P H, Prof, Skjøth, Trine V, MD, Manning, Linda Shapiro, MD, Pi-Sunyer, Xavier, Prof

Get full text